Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/1995
03/21/1995US5399362 Once-a-day metoprolol oral dosage form
03/21/1995US5399361 Collagen-containing sponges as drug delivery compositions for proteins
03/21/1995US5399360 Pharmaceutical compositions
03/21/1995US5399359 Controlled release oxybutynin formulations
03/21/1995US5399358 Sustained release formulations for 24 hour release of metroprolol
03/21/1995US5399357 Sustained release preparations
03/21/1995US5399351 Biocompatible viscoelastic gel slurries, their preparation and use
03/21/1995US5399350 Proteinaceous oil spill dispersant
03/21/1995US5399338 Enhancement of abnormal tissue uptake of antibodies, tumor-specific agents or conjugates thereof for diagnostic imaging or therapy
03/21/1995US5399331 Method for protein-liposome coupling
03/21/1995CA2037057C Photostabilizing method for ophthalmic solutions and the resulting opthalmic solutions therefrom
03/21/1995CA2006714C Absorbable coating and blend
03/21/1995CA2003198C Aqueous ophthalmic solutions and method for preserving same
03/16/1995WO1995007462A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases
03/16/1995WO1995007315A1 Metallospheres and superclusters
03/16/1995WO1995007297A1 Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them
03/16/1995WO1995007104A1 Inclusion complexes of beta-cyclodextrin with flurbiprofen, ketoprofen and naproxen
03/16/1995WO1995007100A1 Compounds for the prevention and treatment of helminth infections
03/16/1995WO1995007097A1 Inhibition of heparin-binding
03/16/1995WO1995007092A1 Blood-brain barrier transporters of neurological agents
03/16/1995WO1995007087A1 Sulfamethoxazole-specific immunosuppressive agents
03/16/1995WO1995007083A1 Ifosfamide lyophilisate composition
03/16/1995WO1995007077A1 Photochemotherapeutic compositions containing 5-aminolevulinic acid
03/16/1995WO1995007076A1 Inclusion complexes of racemic ibuproxam and of optically active ibuproxam with cyclodextrin derivatives, process for the preparation thereof, pharmaceutical preparations containing these inclusion complexes or containing optically active s-(+)-ibuproxam, and use thereof
03/16/1995WO1995007073A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
03/16/1995WO1995004528A3 PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/β-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE
03/16/1995WO1995003050A3 Improved nicotine lozenge and therapeutic method for smoking cessation
03/16/1995WO1995002420A3 Prodrugs of protein tyrosine kinase inhibitors
03/16/1995WO1994027557A3 Pharmaceutical thermal infusion process
03/16/1995DE4331147A1 Aqueous solution which can be administered intravenously
03/16/1995CA2171192A1 Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them
03/16/1995CA2171115A1 Sulfamethoxazole-specific immunosuppressive agents
03/16/1995CA2170623A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases
03/16/1995CA2169633A1 Inhibition of heparin-binding
03/15/1995EP0642799A1 Improved prodrugs for enzyme mediated activation
03/15/1995EP0642798A2 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
03/15/1995EP0642792A1 Stabilized solutions of platinum (II) antitumor agents
03/15/1995EP0642788A2 Tramadol salt containing medicaments with sustained release of the active ingredient
03/15/1995EP0642785A2 Sustained release heterodisperse hydrogel systems for insoluble drugs
03/15/1995EP0642585A1 Activation of oligomerizing receptors by using fused receptor ligands
03/15/1995EP0642580A1 Hepatocyte growth factor variants
03/15/1995EP0642532A1 Proteinoid carriers and methods for preparation and use thereof
03/15/1995EP0642507A1 Catalytic antibodies against cocaine and methods of using and producing same
03/15/1995EP0642355A1 Combined vaccines comprising hepatitis b surface antigen and other antigens
03/15/1995EP0642340A1 Compositions based on histamine h 2?-receptor antagonists and cationic exchangers complexes
03/15/1995EP0642335A1 Controlled release preparation containing a salt of morphine
03/15/1995EP0642334A1 Pharmaceutical and other dosage forms
03/15/1995EP0642332A1 Ophthalmic compositions containing a cyclosporin.
03/15/1995EP0580690B1 Improvements in pharmaceutical compositions
03/15/1995EP0555317B1 Phospholipid analogue vesicle with a succinimidyl moiety
03/15/1995EP0414741B1 Further improvements relating to drug delivery systems
03/15/1995EP0394333B1 Uses of sulphated sugars
03/15/1995CA2132034A1 Intravenously administrable aqueous solution
03/14/1995US5397784 Stable parenteral compositions of vinblastine or vincristine
03/14/1995US5397771 As vehicle for application of biologically active substances to mucosal membranes of mammals, dissolved or suspended
03/14/1995US5397702 Assay for and treatment of autoimmune diseases
03/14/1995US5397591 Infant formula and baby food containing docosahexaenoic acid obtained from dinoflagellates
03/14/1995US5397576 Spray triturated micronutrient compositions
03/14/1995US5397574 Ethyl cellulose coated micropellets of potassium chloride, nonirritating to gastrointestinal tract
03/14/1995US5397567 Gel, especially for ophthalmology
03/14/1995CA2029047C Sustained release compositions for treating periodontal disease
03/09/1995WO1995006659A1 Amine-derivatized nucleosides and oligonucleosides
03/09/1995WO1995006634A1 New 9-chloro-prostaglandin derivatives
03/09/1995WO1995006485A1 Improved pharmaceutical formulation
03/09/1995WO1995006483A1 A method and pharmaceutical and diagnosis compositions for drug targeting
03/09/1995WO1995006482A1 1α,24-(OH)2-VITAMIN D3 EMULSION COMPOSITION
03/09/1995WO1995006464A1 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa
03/09/1995WO1995006463A1 Pharmaceutical compositions containing anionic surfactants
03/09/1995WO1995006461A1 Stabilized tablet formulation
03/09/1995WO1995006460A1 Dispenser containing hydrophobic agent
03/09/1995WO1995001782A3 Method for making freeze dried drug dosage forms
03/09/1995CA2170892A1 Stabilized tablet formulation
03/09/1995CA2170613A1 New 9-chloro-prostaglandin derivatives
03/08/1995EP0641567A1 Stable pharmaceutical compositions containing hybrid alpha-interferon
03/08/1995EP0641359A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects
03/08/1995EP0641217A1 Amylase-electrolyte oral rehydration method and apparatus
03/08/1995EP0641200A1 2-arylpropionic acid compositions and process for preparing the same
03/08/1995EP0641199A1 Solid dispersion compositions of tebufelone
03/08/1995EP0641194A1 Oil-in-water emulsion containing a perfluoropolyether, composition comprising same, preparation method therefor and cosmeticological and dermatological use thereof.
03/08/1995EP0500851B1 Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure
03/08/1995EP0487562B1 Pharmaceutical compositions
03/08/1995EP0443007B1 An external analgesic lotion and method of making
03/08/1995EP0425639B1 Plant protecting preparations, veterinary and additive preparations
03/08/1995CN1099634A Medicine for curing herpes zostor and the preparation thereof
03/07/1995US5395946 Protein labels for diagnosis
03/07/1995US5395924 Blocked lectins; methods and affinity support for making the same using affinity ligands; and method of killing selected cell populations having reduced non-selective cytotoxicity
03/07/1995US5395628 Controlled release succinic acid microcapsules coated with aqueous acrylics
03/07/1995US5395627 Pharmaceutical granulate
03/07/1995US5395619 Lipids joined to polymethyloxazoline
03/07/1995US5395615 Free amine benzophenanthridine alkaloid compositions
03/07/1995EP0654059A4 Copolymers of polyaspartic acid.
03/07/1995CA1334647C Penetration enhancers for transdermal delivery of systemic agents
03/07/1995CA1334646C Transdermal penetration enhancers
03/03/1995CA2712821A1 Use of oxidase inhibitor with dextromethorphan to treat intractable coughing and dermatitis
03/02/1995WO1995006129A2 Transfection process
03/02/1995WO1995006079A1 Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
03/02/1995WO1995006078A1 Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
03/02/1995WO1995006077A2 Polymeric matrices and their uses in pharmaceutical compositions
03/02/1995WO1995006058A1 Polymer modification
03/02/1995WO1995006056A1 Bridged polycationic polymer-oligonucleotide conjugates and methods for preparing same
1 ... 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 ... 1712